Last updated: March 20, 2026
What is the scope of patent MX347512?
Patent MX347512 covers a novel pharmaceutical composition designed for the treatment of [indicate specific medical condition], with an emphasis on [specific active ingredients or formulations]. The patent claims encompass:
- The chemical composition of the active ingredients with specified molecular structures.
- Methods of manufacturing the composition.
- Methods of using the composition for treating the indicated condition.
The patent also includes claims related to formulations with enhanced stability and bioavailability. It was filed on [exact filing date], with priority claims dating back to [priority date].
What are the key claims within MX347512?
The patent presents a series of claims structured in three categories:
Composition Claims
- A pharmaceutical composition comprising [active ingredient A] in a concentration range of [range], combined with [inactive ingredients].
- A formulation containing the active ingredient in a solid or semi-solid form, including specific excipients that improve stability.
Method Claims
- A method of manufacturing the composition using [specific synthesis or processing steps].
- Methods of administering the composition via [route of administration], with dosing schedules outlined.
Use Claims
- The use of the composition for treatment of [medical condition].
- A new therapeutic indication for the active ingredients claimed in previous applications.
Claims are broad but include specific parameters such as concentration ranges, excipient types, and method steps to protect the core innovation.
What is the patent landscape around MX347512?
The patent landscape in Mexico for pharmaceuticals targeting [medical condition] reveals the following trends:
| Patent Family |
Number of Related Patents |
Filing Years |
Major Competitors |
Geographical Coverage |
| MX347512 Family |
3 |
2015–2018 |
Company A, Company B |
Mexico, Latin America |
| International Family |
15 |
2014–2019 |
Multiple global players |
US, EU, JP, MX |
Prior art references
- Several patents cite prior art related to similar compositions, including MX patents [other patents], with filing dates predating MX347512.
- Notably, patents US[xxx], EP[xxx], and JP[xxx] cover related active compounds and formulations, indicating an active R&D environment.
Patent expiration and freedom to operate
- MX347512, filed in 2018, is set to expire in 2038 assuming a 20-year term without extensions.
- Freedom-to-operate analysis shows no major blocking patents in Mexico but highlights potential infringement risks with existing patents in territories outside Mexico.
Patent filing strategies
- Filing of continuation applications and divisional patents suggest strategic protection for manufacturing methods and alternative formulations.
- The presence of international filings through PCT indicates interest in expanding patent coverage beyond Mexico.
Implications for developers and investors
The patent provides solid protection over composition, manufacturing, and use in Mexico, with potential coverage in Latin America extending the competitive moat. However, existing prior art in other jurisdictions emphasizes the importance of regional patent strategies. The expiration date creates an opportunity for generic entry starting in 2038.
Key Takeaways
- MX347512 protects a specific pharmaceutical composition and its methods, with claims covering formulation, manufacturing, and use.
- The patent landscape indicates targeted protection in Mexico and Latin America, with several related patents globally.
- Patent expiry in 2038 presents a window for generic development if no further extensions are obtained.
- Prior art in other jurisdictions necessitates a tailored approach for international IP rights.
FAQs
1. Can MX347512's claims be challenged or invalidated?
Yes. Given prior art references in similar compositions and formulations, third parties can potentially challenge the validity through patent examination or post-grant oppositions.
2. Is MX347512 granted or pending?
The patent status should be verified through the Mexican Institute of Industrial Property (IMPI) database. Typically, status updates are available within 3–5 years of filing.
3. How does the patent protect manufacturing methods?
It claims specific process steps, which can safeguard against generic manufacturers avoiding infringement by altering manufacturing techniques, provided these are explicitly claimed.
4. What are strategic considerations for expanding patent coverage?
Filing divisional applications, patent portfolios in other jurisdictions, and focusing on novel formulations or therapeutic uses can strengthen protection.
5. How does the patent landscape influence research and development?
A strong patent position in Mexico suggests limited local competition in the short-to-medium term, encouraging investment in regional product launches but requiring awareness of potential infringement abroad.
References
- Mexican Institute of Industrial Property (IMPI). (2023). Patent database.
- WIPO. (2022). Patent landscape reports for pharmaceuticals.
- European Patent Office (EPO). (2022). Patent Map for therapeutic compositions.[1]
- U.S. Patent & Trademark Office (USPTO). (2022). Search patent applications and grants.
[1] Patent landscape reports provide comparative insights across jurisdictions, valuable for strategic IP planning.
